E. Coli Testing Market Size by Application, Type, Region – Segment-Level Market Assessment, Growth Opportunity Analysis, Competitive Mapping & Forecast to 2034
Overview
E. coli Testing Market is expected to reach US$ 461.97 million at a CAGR of 6.1% during the forecast period 2034.
Escherichia coli (E. coli) are rod-shaped gram-negative bacteria that are usually found in the environment, foods, and intestines of warm-blooded animals. Most of the E.coli strains are usually harmless to humans, but some strains identified to cause serious diseases like gastrointestinal tract infections, cholangitis, cholecystitis, bacteraemia, neonatal meningitis and pneumonia, urinary tract infection (UTI), which are mostly spread via contaminated food or water.
The growing public awareness, increase in product launches, and numerous FDA approvals for new instruments are the primary drivers for the market growth in this region. Lack of cleanliness and the general negligence of maintaining hygiene has been chiefly responsible for driving the global E. coli testing market. Rising worries about anti-microbial resistance acquired by those affected are also driving the global E. coli testing market, by prompting extensive research on the bacterium, especially with regards to its resistance power. Increasing government support for E. coli testing, increasing occurrence and high illness of E. coli infection globally is expected to drive the future market growth of E. coli testing.
The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
E. coli Testing Market Growth Outlook
To know about the Research Methodology:-Request Free Sample Report
However, high costs of E. coli treatments are especially obstructing the E. coli testing market, mainly by depressing those having less non-refundable income. Many underdeveloped and distant regions show a lack of healthcare experts, consequently restraining the market’s growth. But, extensive research and innovations are being carried out by several players, and this is expected to reduce the restraints up to a certain extent.
Region-wise, the North Americas accounted for almost XX% of the market share in 2025 and is expected to grow at a CAGR of over XX% during the forecast period. Upcoming technological advancement along with rising use of polymerase chain reaction (PCR) tests for environment water testing expected to open up new growth opportunities during the forecast period.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding the global E. Coli Testing market dynamics, structure by identifying and analysing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address questions of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in the global gram E. Coli Testing market.
E. coli Testing Market Recent Development
| Date | Company | Development | Impact |
|---|---|---|---|
| 13 October 2025 | Neogen Corporation | Neogen launched the Neogen MPNTray, expanding its Colitag Water Testing System to provide both quantitative and presence/absence detection for E. coli and total coliforms. | The innovation enhances diagnostic accuracy and operational scalability for municipal water testing laboratories and environmental quality monitoring facilities. |
| 01 October 2025 | Merck KGaA & Bio-Rad Laboratories | Merck KGaA announced a strategic collaboration with Bio-Rad Laboratories to expand advanced molecular diagnostics offerings in food safety, targeting E. coli detection. | The partnership combines commercial footprint and high-throughput diagnostic tools to address strict global regulatory standards in agricultural and food processing supply chains. |
| 15 March 2025 | QIAGEN | QIAGEN received FDA clearance for its QIAstat-Dx Gastrointestinal Panel 2 Mini B, designed for rapid clinical detection of bacterial pathogens including Escherichia coli. | The approval expands point-of-care syndromic testing capabilities in clinical diagnostic laboratories and hospital settings, accelerating treatment decisions for severe gastroenteritis. |
| 13 February 2025 | Sanofi & Johnson & Johnson | Sanofi and Johnson & Johnson announced the conclusion of the Phase 3 E.mbrace trial evaluating a preventive vaccine candidate against extraintestinal pathogenic E. coli disease. | The findings shift competitive R&D focus toward rapid molecular diagnostics and pathogen surveillance tools to manage severe E. coli bloodstream infections. |
E. Coli Testing Market Scope: Inquire before buying
| E. Coli Testing Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | US $ 271.12 Mn. |
| Forecast Period 2026 to 2034 CAGR: | 6.1% | Market Size in 2034: | US $ 461.97 Mn. |
| Segments Covered: | by Application | Hospitals Diagnostic Laboratories Water Treatment Agencies Others |
|
| by Type | Clinical Environmental |
||
E. coli Testing Market by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina, Columbia and Rest of South America)
E. Coli Testing Market Key Players
The Global E. coli Testing Market encompasses the industry-wide sale and use of diagnostic kits, reagents, instruments, and services designed to detect and identify Escherichia coli bacteria.
| Company Name | Headquarters | Core Competencies |
| Abbott Laboratories | Abbott Park, Illinois, USA | Molecular diagnostics, microbiology testing, rapid diagnostic systems |
| Danaher Corporation (Beckman Coulter & Cepheid) | Washington, D.C., USA | Molecular diagnostics, PCR-based pathogen detection, microbiology solutions |
| Thermo Fisher Scientific Inc. | Waltham, Massachusetts, USA | Microbiology testing, PCR assays, food and environmental testing |
| bioMérieux SA | Marcy-l'Étoile, France | Microbial identification, food safety testing, molecular diagnostics |
| Bio-Rad Laboratories, Inc. | Hercules, California, USA | PCR systems, microbiology diagnostics, pathogen detection |
| Siemens Healthineers AG | Erlangen, Germany | Clinical diagnostics, laboratory automation, infectious disease testing |
| F. Hoffmann-La Roche AG | Basel, Switzerland | Molecular diagnostics, PCR systems, infectious disease diagnostics |
| IDEXX Laboratories, Inc. | Westbrook, Maine, USA | Water quality testing, food safety diagnostics, microbiology testing |
| Pro-Lab Diagnostics Inc. | Richmond Hill, Ontario, Canada | Clinical microbiology, culture media, rapid diagnostic kits |
| FUJIFILM Wako Pure Chemical Corporation | Osaka, Japan | Microbiology reagents, culture media, laboratory chemicals |
| Neogen Corporation | Lansing, Michigan, USA | Food safety diagnostics, pathogen detection, rapid microbiological testing |
| Hardy Diagnostics | Santa Maria, California, USA | Culture media, microbiology diagnostics, pathogen detection |
| HiMedia Laboratories Pvt. Ltd. | Mumbai, India | Microbiology culture media, diagnostic kits, laboratory reagents |
| Liofilchem S.r.l. | Roseto degli Abruzzi, Italy | Microbiology diagnostics, culture media, antimicrobial susceptibility testing |
| Romer Labs Division Holding GmbH | Tulln, Austria | Food safety diagnostics, pathogen detection, microbiological testing |
| Eurofins Scientific SE | Luxembourg City, Luxembourg | Food, water and environmental microbiology testing services |
| QIAGEN N.V. | Venlo, Netherlands | Molecular diagnostics, PCR assays, pathogen detection |
| SD Biosensor, Inc. | Suwon, South Korea | Rapid diagnostics, molecular diagnostics, infectious disease testing |
| SGS S.A. | Geneva, Switzerland | Food safety testing, microbiological analysis, laboratory services |
| TÜV SÜD AG | Munich, Germany | Food safety and microbiological testing, laboratory certification |
Frequently Asked Questions:
1. Which region has the largest share in Global E. coli Testing Market?
Ans: North America region held the highest share in 2025.
2. What is the growth rate of Global E. coli Testing Market?
Ans: The Global E. coli Testing Market is growing at a CAGR of 6.1% during forecasting period 2026-2034.
3. What is scope of the Global E. coli Testing market report?
Ans: Global E. coli Testing Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global E. coli Testing market?
Ans: The important key players in the Global E. coli Testing Market are – Abbott Laboratories, Beckman Coulter, Wako, Becton, Dickinson and Company, Affymetrix, bioMrieux, Bio-Rad Laboratories, Thermo Fisher Scientific, Siemens, Hoffmann-La Roche, Cepheid, GenBio, Olympus, Novartis, Johnson & Johnson, Pro-Lab Diagnostics, Inc., IDEXX Laboratories, Inc., Meridian Bioscience, Inc., CPI International, Biomerieux Inc., Hologic, Inc, and
5. What is the study period of this market?
Ans: The Global E. coli Testing Market is studied from 2020 to 2034